Mechanisms of postprandial hyperlipidaemia - Remnants and coronary artery disease

Diabetic Medicine

Volumn 14, Issue SUPPL. 3, 1997, Pages

  Karpe, F ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chylomicron; Coronary artery disease; Hyperlipidaemia; Postprandial; VLDL

Indexed keywords

CHYLOMICRON; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; POSTPRANDIAL STATE; RISK FACTOR;

BLOOD COAGULATION; CHOLESTEROL ESTERS; CHOLESTEROL, DIETARY; CHYLOMICRONS; CORONARY DISEASE; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; POSTPRANDIAL PERIOD;

EID: 0030747671     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199708)14:3+3.0.CO;2-V     Document Type: Article

References (56)

1. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485.
2. Kane JP, Hardman DA, Paulus HE. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci USA 1980; 77: 2465-2469.
3. Nestel PJ. Relationship between plasma triglycerides and removal of chylomicrons. J Clin Invest 1964; 43: 943-949.
4. Goodman DS. Vitamin A metabolism. Fed Proc 1980; 39: 2716-2722.
5. Hazzard WR, Bierman EL. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-β disease (Type III hyperlipoproteinemia). Metabolism 1976; 25: 777-801.
6. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, et al. Postprandial lipaemia, fenofibrate and coronary heart disease. Atherosclerosis 1990; 85: 653-662.
7. Groot PHE, van Stiphout WAHJ, Krauss XH, Jansen H, van Tol A, van Ramshorst E, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary heart disease. Arterioscler Thromb 1991; 11: 653-662.
8. Chan L. Apolipoprotein B, the maJor protein component of triglyceride-rich and low density lipoprotein. J Biol Chem 1992; 267: 25621-25624.
9. Patsch J. Postprandial lipaemia. In: Shepherd J, ed. Baillière's Clinical Endocrinology and Metabolism. 1987; 1: 551-580.
10. Windler E, Greeve J, Robenek H, Rinniger H, Greten H, Jäckle S. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver. Hepatology 1996; 24: 344-351.
11. Frayn KN, Coppack SW, Humphreys SM, Clark ML, Evans RD. Periprandial regulation of lipid metabolism in insulintreated diabetes mellitus. Metabolism 1993; 42: 504-510.
12. Coppack SW, Evans RD, Fisher RM, Frayn KM, Gibbons GF, Humphreys SM, Kirk ML, Potts JL, Hockoday TD. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 1992; 41: 264-272.
13. Brunzell JD, Hazzard WR, Porte D, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest 1973; 52: 1578-1585.
14. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subJects fed a fat-rich meal. J Lipid Res 1988; 29: 925-936.
15. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993; 91: 748-758.
16. Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationship between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 1993; 90: 2069-2073.
17. BJörkegren J, Packard CJ, Hamsten A, Bedford D, Caslake M, Foster L, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996; 37: 76-86.
18. Karpe F, Hultin M. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. J Lipid Res 1995; 36: 1557-1566.
19. Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, et al. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993; 34: 2033-2040.
20. Eisenberg S. Preferential enrichment of larger-sized very low density lipoprotein populations with transferred cholesteryl esters. J Lipid Res 1985; 26: 487-494.
21. Dullaart RPF, Groener JEM, van WiJk H, Sluiter WJ, Erkelens DW. Alimentary lipemia-induced redistribution of cholesterol ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men. Arteriosclerosis 1989; 9: 614-622.
22. Karpe F, Bard J-M, Steiner G, Carlson LA, Fruchart J-C, Hamsten A. HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at young age. Arterioscler Thromb 1993; 13: 11-22.
23. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-2066.
24. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Rumsey SC, et al. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb 1994; 14: 576-586.
25. Dubois C, Armand M, Mekki N, Portugal H, Pauli A-M, Bertrand P-M, et al. Effects of increasing amounts of dietary cholesterol on postprandial lipemia and lipoproteins in human subJects. Am J Clin Nutr 1994; 35: 1993-2007.
26. Clifton PM, Nestel PJ. Effect of dietary cholesterol on postprandial lipoproteins in three phenotypic groups. Am J Clin Nutr 1996; 64: 361-367.
27. Dubois C, Armand M, Ferezou J, Beaumier G, Portugal H, Pauli A-M, et al. Postprandial appearance of dietary deuterated cholesterol in the chylomicron fraction and whole plasma in healthy subJects. Am J Clin Nutr 1996; 64: 47-52.
28. Silveira A, Karpe F, Blomback M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 1994; 14: 60-69.
29. Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vase Biol 1996; 16: 1333-1339.
30. Kissebah AH, Alfarsi S, Evans DJ, Adams PW. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 1982; 31: 217-225.
31. Chen YD, Golay A, Swislocki AL, Reaven CM. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987; 64: 17-21.
32. Fraze F, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985; 61: 807-811.
33. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of tree fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991; 72: 96-107.
34. Chen YD, Swami S, Skrowronski R, Coulston AM, Reaven GM. Differences in postprandial lipemia between patients with normal glucose tolerance and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 76: 172-177.
35. Chen YD, Coulston AM, Zhou MY, Hollenbeck CB, Reaven GM. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM? Diabetes Care 1995; 18: 10-16.
36. Sprecher DL, Knauer SL, Black DM, Kaplan LA, Akeson AA, Dusing M, et al. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. J Clin Invest 1991; 88: 985-994.
37. Krasinski SD, Cohn JS, Russell RM, Schaefer EJ. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism 1990; 39: 357-365.
38. Karpe F, Bell M, BJörkegren J, Hamsten A. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler Thromb Vase Biol 1995; 15: 199-207.
39. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, laina A. Clearance of chylomicron remnants in normolipidemic patients with coronary artery disease: case control study over three years. Br Med J 1996; 312: 935-939.
40. Syvänne M, Hilden H, Taskinen M-R. Abnormal metabolism of postprandial lipoproteins in non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 1994; 35: 15-26.
41. Poapst M, Uffelman K, Steiner G. The chromogenicity and quantitation of apoB-100 and apoB-48 of human plasma tipoproteins on analytical SDS gel electrophoresis. Atherosclerosis 1987; 65: 75-88.
42. Zilversmit DB, Shea TM. Quantification of apoB-48 and apoB-100 by gel scanning and radio-iodination. J Lipid Res 1989; 30: 1639-1646.
43. Karpe F, Hamsten A. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 1994; 35: 1311-1317.
44. Kotite L, Bergeron N, Havel RJ. Quantification of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins. J Lipid Res 1995; 36: 890-900.
45. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-1345.
46. Uiterwaal CSPM, Grobbee DE, Witteman JCM, van Stiphout WAHJ, Krauss XH, Havekes LM, et al. Postprandial triglyceride responses in young adult men and familial atherosclerosis. Ann Intern Med 1994; 121: 576-583.
47. Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994; 5: 102-109.
48. BJörkegren J, Hamsten A, Milne RW, Karpe F. Alteration of VLDL composition during alimentary lipaemia. J Lipid Res 1997; 38: 143-156.
49. Simons EA, Dwyer T, Simons J, Bernstein P, Mock P, Poonia NS, et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987; 65: 181-189.
50. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
51. Karpe F, Tornvall P, Olivecrona T, Steiner G, Carlson EA, Hamsten A. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 1993; 98: 33-49.
52. Phillips NR, Waters W, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993; 88: 2762-2770.
53. Tornvall P, Båvenholm P, Landou C, de Faire U, Hamsten A. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88: 2180-2189.
54. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, et al. Triglyceride- and cholesterol-rich lipoproteins have differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial on Lovastatin. Circulation 1994; 90: 42-49.
55. Rapp JH, Lespine A, Hamilton RE, Colyvas N, Chaumeton AH, Tweedie-Hardman J, et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorbtion from human atherosclerotic plaque. Arterioscler Thromb 1994; 14: 1767-1774.
56. Hamsten A. The hemostatic system and coronary heart disease. Thromb Res 1993; 70: 1-38.